Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andre A. R. Teixeira"'
Autor:
Fortunato Ferrara, Adeline Fanni, Andre A. R. Teixeira, Esteban Molina, Camila Leal-Lopes, Ashley DeAguero, Sara D’Angelo, M. Frank Erasmus, Laura Spector, Luis Antonio Rodriguez Carnero, Jianquan Li, Thomas J. Pohl, Nikolai Suslov, Klervi Desrumeaux, Conor McMahon, Sagar Kathuria, Andrew R. M. Bradbury
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
We previously described an in vitro single-chain fragment (scFv) library platform originally designed to generate antibodies with excellent developability properties. The platform design was based on the use of clinical antibodies as scaffolds into w
Externí odkaz:
https://doaj.org/article/08adf8bbba7940a8b4cc3c5378c32316
Autor:
Andre A. R. Teixeira, Sara D’Angelo, M. Frank Erasmus, Camila Leal-Lopes, Fortunato Ferrara, Laura P. Spector, Leslie Naranjo, Esteban Molina, Tamara Max, Ashley DeAguero, Katherine Perea, Shaun Stewart, Rebecca A. Buonpane, Horacio G. Nastri, Andrew R. M. Bradbury
Publikováno v:
mAbs, Vol 14, Iss 1 (2022)
Affinity maturation is often a necessary step for the development of potent therapeutic molecules. Many different diversification strategies have been used for antibody affinity maturation, including error-prone PCR, chain shuffling, and targeted com
Externí odkaz:
https://doaj.org/article/33ec78a25c5c442aa8059bd64ee24afc
Autor:
Teixeira, Andre A. R., D'Angelo, Sara, Erasmus, M. Frank, Leal-Lopes, Camila, Ferrara, Fortunato, Spector, Laura P., Naranjo, Leslie, Molina, Esteban, Max, Tamara, DeAguero, Ashley, Perea, Katherine, Stewart, Shaun, Buonpane, Rebecca A., Nastri, Horacio G., Bradbury, Andrew R. M.
Publikováno v:
mAbs; Jan-Dec2022, Vol. 14 Issue 1, p1-14, 14p
Publikováno v:
Vaccine Weekly; 1/26/2024, p153-153, 1p
Publikováno v:
Drug Week; 12/01/2023, p1362-1362, 1p
Autor:
Fathi, Esmat, Katouli, Fatemeh, Riazi, Gholam, Shasaltaneh, Marzieh, Parandavar, Elham, Bayati, Samaneh, Afrasiabi, Ali, Nazari, Reza
Publikováno v:
NeuroMolecular Medicine; Mar2017, Vol. 19 Issue 1, p136-146, 11p
Autor:
Leal-Lopes C; New Mexico Consortium, 4200 W. Jemez Rd, Suite 301, Los Alamos, NM 87544, USA., D'Angelo S; Specifica Inc, a Q2 Solution Company, 1607 Alcaldesa Street, Santa Fe, NM 87501, USA., Erasmus MF; Specifica Inc, a Q2 Solution Company, 1607 Alcaldesa Street, Santa Fe, NM 87501, USA., Teixeira AAR; New Mexico Consortium, 4200 W. Jemez Rd, Suite 301, Los Alamos, NM 87544, USA., Temples G; Purilogics, a Donaldson Brand, 900B W Faris Rd., Greenville, SC 29605, USA., Zhou J; Purilogics, a Donaldson Brand, 900B W Faris Rd., Greenville, SC 29605, USA., Bradbury ARM; Specifica Inc, a Q2 Solution Company, 1607 Alcaldesa Street, Santa Fe, NM 87501, USA. Electronic address: abradbury@specifica.bio., Ferrara F; Specifica Inc, a Q2 Solution Company, 1607 Alcaldesa Street, Santa Fe, NM 87501, USA. Electronic address: fferrara@specifica.bio.
Publikováno v:
New biotechnology [N Biotechnol] 2023 Nov 25; Vol. 77, pp. 111-119. Date of Electronic Publication: 2023 Aug 28.